trihexyphenidyl has been researched along with Bilirubin Encephalopathy in 1 studies
Trihexyphenidyl: One of the centrally acting MUSCARINIC ANTAGONISTS used for treatment of PARKINSONIAN DISORDERS and drug-induced extrapyramidal movement disorders and as an antispasmodic.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Appendino, JP | 1 |
| Soman, T | 1 |
1 other study available for trihexyphenidyl and Bilirubin Encephalopathy
| Article | Year |
|---|---|
Correspondence on "Prospective open-label clinical trial of trihexyphenidyl in children with secondary dystonia due to cerebral palsy".
Topics: Adolescent; Cerebral Palsy; Child; Child, Preschool; Clinical Trials as Topic; Dystonia; Humans; Ker | 2008 |